ASSOCIATION FOR ACCESSIBLE MEDICINES
Lobbying client. Federal LDA filings.
Connected on the graph
Inbound (23)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Greg Barnes | lobbied_for | — | lda_lobbyist_client | |
| — | Michael Burley | lobbied_for | — | lda_lobbyist_client | |
| — | John Mason Long | lobbied_for | — | lda_lobbyist_client | |
| — | Zachary Benjamin Friend | lobbied_for | — | lda_lobbyist_client | |
| — | Cristina Antelo | lobbied_for | — | lda_lobbyist_client | |
| — | Michael Taggart | lobbied_for | — | lda_lobbyist_client | |
| — | Heather Turnbull | lobbied_for | — | lda_lobbyist_client | |
| — | Katelyn Schultz | lobbied_for | — | lda_lobbyist_client | |
| — | John Strom | lobbied_for | — | lda_lobbyist_client | |
| — | Debra Dixon | lobbied_for | — | lda_lobbyist_client | |
| — | William David Rubin | lobbied_for | — | lda_lobbyist_client | |
| — | Kara-Marie Urban | lobbied_for | — | lda_lobbyist_client | |
| — | Mark Williams | lobbied_for | — | lda_lobbyist_client | |
| — | Everett Eissenstat | lobbied_for | — | lda_lobbyist_client | |
| — | Joseph H Gibson | lobbied_for | — | lda_lobbyist_client | |
| 2026-01-01 | TWINLOGIC STRATEGIES, LLP | lobbies_for | — | lda_filing | |
| 2026-01-01 | SQUIRE PATTON BOGGS | lobbies_for | $30,000 | lda_filing | |
| 2026-01-01 | THE GIBSON GROUP, LLC | lobbies_for | $60,000 | lda_filing | |
| 2026-01-01 | RUBIN, TURNBULL & ASSOCIATES | lobbies_for | $150,000 | lda_filing | |
| 2026-01-01 | FEROX STRATEGIES | lobbies_for | — | lda_filing | |
| 2026-01-01 | FEROX STRATEGIES | lobbies_for | $40,000 | lda_filing | |
| 2025-01-01 | SQUIRE PATTON BOGGS | lobbies_for | — | lda_filing | |
| 2025-01-01 | FOLEY & LARDNER LLP | lobbies_for | — | lda_filing |
Outbound (3)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | S 1040 — Drug Competition Enhancement Act | — | S. 1040 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1041 — Affordable Prescriptions for Patients Act | — | S. 1041 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1096 — Preserve Access to Affordable Generics and Biosimilars Act | — | S. 1096 | lobbying_bill_mention |
- Source id
72007- General description
- Trade association for generics and biosimilar manufacturers.
- State
- DC
- Country
- US
- Principal place of business
- US
- Effective date
- 2026-01-01
- Total spend (across 2 ingested filings)
- $40,000
Filings
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-17 | Q1 | 2026 | FEROX STRATEGIES | $40,000 |
| 2026-03-27 | RR | 2026 | FEROX STRATEGIES | — |